| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| GLPG2938 |
GLPG2938 |
2130996-00-6 |
詳細
|
| MIPS-521 |
MIPS-521 |
1146188-19-3 |
詳細
|
| BRD0639 |
化合物BRD0639 |
|
詳細
|
| NA |
|
148706-15-7 |
詳細
|
| CK-274 |
AFICAMTEN |
2364554-48-1 |
詳細
|
| 5-Thiazolecarboxamide, N-[(2S)-2-(4-chlorophenyl)-2-(4-morpholinyl)ethyl]-2-(2-pyrimidinyl)-4-(trifluoromethyl)- |
5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF |
2097117-06-9 |
詳細
|
| N-[4-(6-Fluoro-3,4-dihydro-2(1H)-isoquinolinyl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide |
N-[4-(6-氟-3,4-二氫-2(1H)-異喹啉基)-2,6-二甲基苯基]-3,3-二甲基丁酰胺 |
1009344-33-5 |
詳細
|
| KL-11743 |
KL11743 |
1369452-53-8 |
詳細
|
| AMP-945 |
AMP-945 |
1393653-34-3 |
詳細
|
| SKF 89976A hydrochloride |
1 - (4,4 - 二苯基-3 - 丁烯基)- 3 -哌啶鹽酸鹽 |
85375-15-1 |
詳細
|
| YTX-465Chemical Structure |
YTX-465 |
2225824-53-1 |
詳細
|
| RY785 |
RY785 |
1393748-80-5 |
詳細
|
| SCD1 inhibitor-3 |
化合物SCD1 INHIBITOR-3 |
1282606-48-7 |
詳細
|
| ML339 |
化合物ML339 |
2579689-83-9 |
詳細
|
| Bocidelpar |
化合物BOCIDELPAR |
2095128-20-2 |
詳細
|
| KN-62 |
1-[N,O-二(5-異喹啉磺酰基)-N-甲基-L-型酪氨酸]-4-苯基哌嗪 |
127191-97-3 |
詳細
|
| Ximelagatran |
希美加群 |
192939-46-1 |
詳細
|
| SR 1664 |
4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid |
1338259-05-4 |
詳細
|
| Complement factor D-IN-2 |
2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2-[2-[3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-, (1R,3S,5R)- |
1903742-34-6 |
詳細
|
| JQKD-82 |
JQKD-82 |
2410512-38-6 |
詳細
|
| 1-Piperidinamine, N-hydroxy-N-nitroso- |
|
56329-24-9 |
詳細
|
| INE963 |
化合物INE963 |
2640567-43-5 |
詳細
|
| GSK251 |
GSK251 |
2125968-05-8 |
詳細
|
| 4-Borono-D-phenylalanine |
4-硼-D-苯丙氨酸 B10 |
111821-49-9 |
詳細
|
| Inaxaplin |
化合物INAXAPLIN |
2446816-88-0 |
詳細
|
| EN106 |
EN 106 |
757192-67-9 |
詳細
|
| CDK4/6-IN-6 |
CDK4/6-IN-6 |
2380321-51-5 |
詳細
|
| SOD1-Derlin-1 inhibitor 56-59 |
SOD1-Derlin-1 inhibitor 56-59 |
2170170-27-9 |
詳細
|
| Isothiazolo[5,4-b]pyridin-6-amine |
異噻唑并[5,4-B]吡啶-6-胺 |
1352905-20-4 |
詳細
|
| 3-amino-N-(2,4-dibromophenyl)-6-(pyridin-3-yl)thieno[2,3-b]pyridine-2-carboxamide |
化合物T60119 |
840461-03-2 |
詳細
|
| NCRW0005-F05 |
化合物NCRW0005-F05 |
342779-66-2 |
詳細
|
| Tebanicline hydrochloride |
ABT594鹽酸鹽 |
203564-54-9 |
詳細
|
| 3-Piperidinecarboxamide, N-(4,6-difluoro-2-benzothiazolyl)-1-[2-(dimethylamino)ethyl]- |
化合物MCUF-651 |
2747162-85-0 |
詳細
|
| CEE321 |
4-((2-氯苯基)氨基)-6-((6-甲基吡啶-2-基)氨基)煙酰胺 |
2098545-89-0 |
詳細
|
| TC-G 1001 |
TC-G 1001 |
494191-73-0 |
詳細
|
| 2-Piperidinemethanol, 1-[2-[4-[[4-(3,4-dichlorophenyl)-2-thiazolyl]amino]phenyl]ethyl]-4-hydroxy-, (2R,4S)- |
化合物 AMGEN-23 |
1448706-15-7 |
詳細
|
| ONT-093 |
ONT-093 |
216227-54-2 |
詳細
|
| WAY- 639483 |
WAY-639483 |
791125-94-5 |
詳細
|
| Eliapixant |
依利哌嗪 |
1948229-21-7 |
詳細
|
| AZD-9574 |
AZD-9574 |
2756333-39-6 |
詳細
|
| AOH1996 |
AOH1996 |
2089314-64-5 |
詳細
|
| CD 12322 |
恩格列凈雜質(zhì)B |
|
詳細
|
| (R)-(-)-3-Hydroxytetrahydrofuran |
恩格列凈雜質(zhì)C |
86087-24-3 |
詳細
|
| Empagliflozin Impurity D |
恩格列凈雜質(zhì)D |
|
詳細
|
| Empagliflozin impurity K |
恩格列凈雜質(zhì)K |
|
詳細
|
| Empagliflozin Impurity 17 |
恩格列凈雜質(zhì)L |
2452301-27-6 |
詳細
|
| Empagliflozin Impurity N |
恩格列凈雜質(zhì)N |
|
詳細
|
| EMpagliflozin iMpurity 6 |
恩格列凈雜質(zhì)M |
1620758-21-5 |
詳細
|
| Empagliflozin Impurity O |
恩格列凈雜質(zhì)O |
|
詳細
|
| RIPK2 inhibitor OD36 |
6-Chloro-10,11,14,17-tetrahydro-13H-1,16-etheno-4,8-metheno-1H-pyrazolo[3,4-g][1,14,4,6]dioxadiazacyclohexadecine hydrochloride |
1638644-62-8 |
詳細
|
| Beigene-283 |
LIFIRAFENIB |
1446090-79-4 |
詳細
|
| WAY-600 |
6-(1H-吲哚-5-基)-4-(4-嗎啉基)-1-[1-(3-吡啶基甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶 |
1062159-35-6 |
詳細
|
| WAY-332006 |
WAY-332006 |
901751-85-7 |
詳細
|
| WAY-331996 |
WAY-331996 |
902168-07-4 |
詳細
|
| WAY-603656 |
WAY-603656 |
717118-15-5 |
詳細
|